Corrigendum to Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis [Rheumatology, 52, (2013) 669-675] DOI:10.1093/rheumatology/kes347;Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis

Rheumatology (United Kingdom)

Volumn 52, Issue 4, 2013, Pages 669-675

  Jewett, Lisa R ^a,b   Razykov, Ilya ^b,c   Hudson, Marie ^b,c   Baron, Murray ^b,c   Thombs, Brett D ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Department of Psychiatry ^*  (Canada)

Author keywords

Depression; Major depressive disorder; Psychosocial.; Scleroderma; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; DEMOGRAPHY; FEMALE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 84875604008     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu311     Document Type: Erratum

References (22)

1. Seibold J, Harris ED, Budd RC et al. Kelley's textbook of rheumatology. Philadelphia: Elsevier, 2005.
2. Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246_55.
3. Klippel JH, Stone JH, Crafford LJ, White PH, eds. Primer on the rheumatic diseases, 13th edn. New York: Springer, 2008.
4. Thombs BD, van Lankveld W, Bassel M et al. Psychological health and well-being in systemic sclerosis: state of the science and consensus research agenda. Arthritis Care Res 2010;62:1181_9.
5. Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007;57:1089_97.
6. Baubet T, Ranque B, Taieb O et al. Mood and anxiety disorders in systemic sclerosis patients. Presse Med 2011;40:e111_9.
7. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13: 93_121.
8. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202_5.
9. Medsger TA Jr, Silman AJ, Steen VD et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159_67.
10. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21(Suppl. 29): S42_6.
11. Agresti A, Coull BA. Approximate is better than 'exact' for interval estimation of binomial proportions. Am Stat 1998; 52:119_26.
12. Kessler RC, Berglund P, Demler O et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289: 3095_105.
13. Patten SB, Wang JL, Williams JV et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry 2006;51:84_90.
14. Evans DL, Charney DS, Lewis L et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005;58:175_89.
15. Stang PE, Brandenburg NA, Lane MC et al. Mental and physical comorbid conditions and days in role among persons with arthritis. Psychosom Med 2006;68:152_8.
16. He Y, Zhang M, Lin EH et al. Mental disorders among persons with arthritis: results from the World Mental Health Surveys. Psychol Med 2008;38:1639_50.
17. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22_33.
18. Richards D. Prevalence and clinical course of depression: a review. Clin Psychol Rev 2011;31:1117_25.
19. Newton EG, Thombs BD, Groleau G. The experience of emotional distress among women with scleroderma. Qual Health Res 2012;22:1195_206.
20. Sö llner W, Maislinger S, Konig A, Devries A, Lukas P. Providing psychosocial support for breast cancer patients based on screening for distress within a consultationliaison service. Psychooncology 2004;13:893_7.
21. Jewett LR, Hudson M, Thombs BD. A 38-year-old woman with elevated muscle enzymes, Raynaud's phenomenon and positive anti-topoisomerase I antibody: is she depressed? In: Silver RM, Denton CP, eds. Case studies in systemic sclerosis. New York: Springer, 2011:229_38.
22. McMahan ZH, Wigley FM. Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management. Int J Clin Rheumtol 2010;5: 355_370.